GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TiumBio Co Ltd (XKRX:321550) » Definitions » EV-to-EBITDA
中文

TiumBio Co (XKRX:321550) EV-to-EBITDA : -12.46 (As of Apr. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is TiumBio Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, TiumBio Co's enterprise value is ₩165,903 Mil. TiumBio Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-13,313 Mil. Therefore, TiumBio Co's EV-to-EBITDA for today is -12.46.

The historical rank and industry rank for TiumBio Co's EV-to-EBITDA or its related term are showing as below:

XKRX:321550' s EV-to-EBITDA Range Over the Past 10 Years
Min: -74.54   Med: -14.37   Max: -4.74
Current: -12.46

During the past 7 years, the highest EV-to-EBITDA of TiumBio Co was -4.74. The lowest was -74.54. And the median was -14.37.

XKRX:321550's EV-to-EBITDA is ranked worse than
100% of 474 companies
in the Biotechnology industry
Industry Median: 9.165 vs XKRX:321550: -12.46

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-25), TiumBio Co's stock price is ₩7140.00. TiumBio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-734.000. Therefore, TiumBio Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


TiumBio Co EV-to-EBITDA Historical Data

The historical data trend for TiumBio Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TiumBio Co EV-to-EBITDA Chart

TiumBio Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial -52.15 -39.29 -14.90 -10.79 -17.35

TiumBio Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.79 -7.18 -6.57 -6.67 -17.35

Competitive Comparison of TiumBio Co's EV-to-EBITDA

For the Biotechnology subindustry, TiumBio Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TiumBio Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TiumBio Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where TiumBio Co's EV-to-EBITDA falls into.



TiumBio Co EV-to-EBITDA Calculation

TiumBio Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=165902.790/-13312.863
=-12.46

TiumBio Co's current Enterprise Value is ₩165,903 Mil.
TiumBio Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-13,313 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TiumBio Co  (XKRX:321550) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

TiumBio Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7140.00/-734.000
=At Loss

TiumBio Co's share price for today is ₩7140.00.
TiumBio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-734.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


TiumBio Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of TiumBio Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


TiumBio Co (XKRX:321550) Business Description

Traded in Other Exchanges
N/A
Address
49, Daewangpangyo-ro 644beon-gil, Bundang-gu, 4th floor, Gyeonggi, Seongnam, KOR, 13493
TiumBio Co Ltd is a Biopharmaceutical company. It is engaged in research and development of rare and intractable diseases. The company's products are in pipeline. It offers products such as Idiopathic pulmonary fibrosis therapies, immune chemotherapy, endometriosis therapies, hemophilia.

TiumBio Co (XKRX:321550) Headlines

No Headlines